Seres Therapeutics, Inc. (MCRB) earnings
Quarterly results of Seres Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Seres Therapeutics, Inc. was expected to report around November 4, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Seres Therapeutics, Inc. reported revenue of $736K and net income of $4.6M.
Diluted earnings per share were $0.47.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $736K | - | $4.6M | $0.47 |
| Q1 FY2026 | $358K | - | -$19.9M | -$2.08 |
| Q4 FY2025 | $438K | - | -$15.3M | - |
| Q3 FY2025 | $351K | - | $8.2M | $0.94 |
| Q2 FY2025 | $0 | - | -$19.9M | -$2.27 |
| Q1 FY2025 | $0 | - | $32.7M | $3.75 |
| Q4 FY2024 | $0 | - | -$15.6M | - |
| Q3 FY2024 | $0 | - | $88.8M | $11.63 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Seres Therapeutics, Inc.'s next earnings date?
Seres Therapeutics, Inc. was expected to report around November 4, 2026; nothing is on file with the SEC yet.
What were Seres Therapeutics, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Seres Therapeutics, Inc. reported revenue of $736K and net income of $4.6M. The figures come from its filing with the SEC.
Get an email when MCRB reports
Follow MCRB and we email you its next results the day they are filed, with the numbers explained.